Investigational Site Number 250002

Paris 75651

0 studies enrolling now · 6 studies all time

What they study most

Acid Maltase Deficiency, Glycogen Storage Disease Type II (GSD II), Glycogen Storage Disease Type II Pompe Disease, Hematopoietic Neoplasm, Hypercholesterolemia, Ovarian Cancer Recurrent, Pompe Disease, Uveitis

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Avalglucosidase Alfa Extension Study — Completed
• Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients. — Completed
• Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis — Completed
• Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term) — Completed
• Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel — Completed